Live Breaking News & Updates on Andrew Calam

Stay updated with breaking news from Andrew calam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Appointments consolidate position in Antibody-based Therapeutics

Novel immunoglobulin E (IgE) antibodies developer Epsilogen has announced a significant expansion of their management team, with the appointments of Nick Robbins-Cherry joins as Chief Financial Officer, Andrew Calam as Vice President of Clinical Operations and Elizabeth Hardaker as Vice President of Biology. Click to read more. ....

Elizabeth Hardaker , Nick Robbins , Tim Wilson , Andrew Calam , National Heart , Imperial College , Clinical Development At Syneos Health , Bath University , Ixaka Ltd , Lung Institute , Nick Robbins Cherry , Chief Financial Officer , Vice President , Clinical Operations , Chartered Accountant , Executive Director , Clinical Development , Syneos Health , Senior Director ,

Epsilogen announces significant expansion of management team with three new senior hires

L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu. ....

City Of , United Kingdom , Andrew Calam , Tim Wilson , Simon Conway Rob Winder , Elizabeth Hardaker , Nick Robbins , Epsilogen Ltd , National Heart , King College London , Bath University , Clinical Development At Syneos Health , Business Wire Inc , Ixaka Ltd , B Future Health Fund , Novartis Venture Fund , Lung Institute , Midatech Pharma , Imperial College , Chief Financial Officer , Vice President , Clinical Operations , Chartered Accountant , Executive Director , Clinical Development , Syneos Health ,